During routine horizon scanning, RDTC have identified adrenaline 2mg nasal spray (Eurneffy) for management of severe allergic reactions as an item of interest. We’ve added it to our workplan, but we’re aware that the Resuscitation Council UK clinical guidelines are due for review. To avoid duplication of effort we are awaiting this updated guidance, and will keep this topic under active surveillance,
